OBJECTIVE: To determine if cellular and soluble HLA-DR molecules may be relevant in severely injured patients for the development of gram-positive or gram-negative sepsis. SUMMARY BACKGROUND DATA: HLA-DR molecules play a central role in the specific immune response to infection. The reduced HLA-DR expression on monocytes is considered to correlate with infectious complications and the development of sepsis. Data on the role of HLA-DR expression on T cells and soluble HLA-DR molecules are rare. METHODS: HLA-DR expression on monocytes and T cells was measured by flow cytometry. Plasma levels of soluble HLA-DR were studied by enzyme-linked immunosorbent assay. RESULTS: HLA-DR expression on circulating T cells, calculated as mean fluorescence intensity in channels, was reduced at day 1 after admission in 20 patients with subsequent severe sepsis compared with 46 patients without sepsis. The septic patients immediately after trauma had significantly lower soluble HLA-DR plasma levels than the nonseptic patients. At day 2 after admission, HLA-DR expression on monocytes was significantly lower in the severe sepsis group than in the patients without sepsis, and lasted until day 14 after injury. CONCLUSIONS: In severely injured patients, decreased levels of cellular and soluble HLA-DR appear as early indicators of an immune deviation associated with the development of severe sepsis. Moreover, immune alterations of different cell types may promote distinct kinds of septicemia.
OBJECTIVE: To determine if cellular and soluble HLA-DR molecules may be relevant in severely injured patients for the development of gram-positive or gram-negative sepsis. SUMMARY BACKGROUND DATA: HLA-DR molecules play a central role in the specific immune response to infection. The reduced HLA-DR expression on monocytes is considered to correlate with infectious complications and the development of sepsis. Data on the role of HLA-DR expression on T cells and soluble HLA-DR molecules are rare. METHODS: HLA-DR expression on monocytes and T cells was measured by flow cytometry. Plasma levels of soluble HLA-DR were studied by enzyme-linked immunosorbent assay. RESULTS: HLA-DR expression on circulating T cells, calculated as mean fluorescence intensity in channels, was reduced at day 1 after admission in 20 patients with subsequent severe sepsis compared with 46 patients without sepsis. The septicpatients immediately after trauma had significantly lower soluble HLA-DR plasma levels than the nonseptic patients. At day 2 after admission, HLA-DR expression on monocytes was significantly lower in the severe sepsis group than in the patients without sepsis, and lasted until day 14 after injury. CONCLUSIONS: In severely injured patients, decreased levels of cellular and soluble HLA-DR appear as early indicators of an immune deviation associated with the development of severe sepsis. Moreover, immune alterations of different cell types may promote distinct kinds of septicemia.
Authors: H Burgmann; S Winkler; G J Locker; E Presterl; K Laczika; T Staudinger; S Knapp; F Thalhammer; C Wenisch; K Zedwitz-Liebenstein; M Frass; W Graninger Journal: Clin Immunol Immunopathol Date: 1996-09
Authors: F Kanakoudi-Tsakalidou; F Debonera; V Drossou-Agakidou; K Sarafidis; V Tzimouli; A Taparkou; G Kremenopoulos Journal: Clin Exp Immunol Date: 2001-03 Impact factor: 4.330
Authors: A Januszkiewicz; K Loré; P Essén; B Andersson; M A McNurlan; P J Garlick; O Ringdén; J Andersson; J Wernerman Journal: Clin Exp Immunol Date: 2002-11 Impact factor: 4.330
Authors: Motaz Qadan; Sarah A Gardner; David S Vitale; David Lominadze; Irving G Joshua; Hiram C Polk Journal: Ann Surg Date: 2009-07 Impact factor: 12.969
Authors: Todd A Baker; Jacqueline Romero; Harold H Bach; Joel A Strom; Richard L Gamelli; Matthias Majetschak Journal: Crit Care Med Date: 2012-03 Impact factor: 7.598
Authors: P G Boelens; J C M Fonk; A P J Houdijk; R J Scheper; H J T H M Haarman; S Meijer; P A M Van Leeuwen; B M E von Blomberg-van der Flier Journal: Clin Exp Immunol Date: 2004-05 Impact factor: 4.330
Authors: Gabriela K Fragiadakis; Brice Gaudillière; Edward A Ganio; Nima Aghaeepour; Martha Tingle; Garry P Nolan; Martin S Angst Journal: Anesthesiology Date: 2015-12 Impact factor: 7.892
Authors: Jung-Sun Kim; Roberto Romero; Adi Laurentiu Tarca; Christopher LaJeunesse; Yu Mi Han; Mi Jeong Kim; Yeon Lim Suh; Sorin Draghici; Pooja Mittal; Francesca Gotsch; Juan Pedro Kusanovic; Sonia Hassan; Chong Jai Kim Journal: J Cell Mol Med Date: 2008-02-24 Impact factor: 5.310